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Summary Clonogenic survival of HeLa, Chinese hamster and HaK cells after treatment with a range of
cisplatin concentrations and exposure times was determined and cellular platinum concentrations were
measured by PIXE. It was demonstrated that cisplatin cytotoxicity of the three cell lines varied considerably
as a function of drug exposure dose. These differences are related to differential cellular drug uptake.
Sensitivity to cisplatin has been shown to vary
considerably between different cell lines (Bergerat et
al., 1979; Fraval & Roberts, 1979). This may be
related to the specific cytotoxic action of the drug
which interacts with DNA by monofunctional
binding to bases, chelation or bifunctional cross-
linking to bases in the helix, either on the same
strand or on opposite strands (Douple &
Richmond, 1979). Relative cytotoxicity has been
related to the amount of Pt bound to the DNA
(Fraval & Roberts, 1979) or to interstrand cross-
links (Zwelling et al., 1979).
We have studied cisplatin action on HeLa,
Chinese hamster and HaK cells, which display large
differences in drug sensitivity to cisplatin. The aim
of our study was to investigate the correlation
between drug cytotoxicity and platinum uptake into
the cells.
Materials and methods
Cell cultures
Experiments were carried out with the following
three cell lines: B 14F28 Chinese hamster cells, a
lung fibroblast cell line with a mean cell cycle time
of 12h; HeLa S 3 cells and HaK cells (Syrian
hamster kidney cells, Flow Laboratories) with an
average cell cycle time of 20h. Monolayer cultures
of all cell lines were cultured in Eagle's minimum
essential medium (MEM), supplemented with 10%
calf serum, 0.01% neomycine, and 0.035%
NAHCO3. They were kept in a humified CO2
incubator at pH 7.4 and 37°C (for further details,
see Eichholtz-Wirth, 1980).
Drug exposure
Cis-diammine-dichloro-platinum (cisplatin), Platinex-
solution, Bristol Myers, was used and appropriately
diluted in Hank's solution immediately before use.
Exponentially growing cells were subcultured and
appropriately diluted. Four hours after seeding,
cisplatin was added to the culture medium, and the
cells were incubated for the appropriate exposure
time. After exposure the medium was removed, the
cells rinsed twice with Hank's solution and fresh
culture medium added.
Cell survival
After incubation for 8 days (Chinese hamster cells)
or 14 days (HeLa and HaK cells) the colonies were
stained with methylene blue and those containing
more than 50 cells were counted. The ratio of mean
colony yields of treated to untreated cells - the
surviving fraction (SF) - was calculated. All experi-
ments were carried out with 4 replicate bottles and
repeated at least 3 times. Experimental data were
accepted if the colony forming efficiency of the
untreated cells was higher than 35% and if x2 of all
replicates was within a probability of 95%.
Cellular concentration ofcisplatin
The cellular concentration of platinum was
determined with proton induced characteristic X-
ray emission (PIXE, Johansson et al., 1970). PIXE
analysis is based on the fact that energetic ions
incident on samples under investigation produce
characteristic X-ray lines with energies dependent
on the atomic number and with intensities propor-
tional to the beam current and the number of the
atoms in the material. It was performed in vacuum
target chambers connected to the beam line system
of a van de Graaff accelerator. Because of the
various advantages for routine analysis we used the
external beam technique. In this case the sample
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was mounted in a chamber filled with helium at
atmospheric pressure. The proton beam (energy:
2.8MeV, beam current 200-300nA), supplied by a
3MV van de Graaff accelerator left the vacuum
system through a thin metal window (8Mm
aluminium) and hit the sample. The external beam
method allowed the analysis of wet or liquid
samples and was advantageous regarding the
exchange and the cooling of the samples.
For the determination of cellular platinum
content 1 resp. 2 x 106 cells (106 cells per bottle)
were treated with cisplatin for the appropriate time
and rinsed twice with Hank's solution. The cells
were then scraped off the glass with rubber and
centrifuged (1000g, 10min). The cells were lyzed by
deep freezing and thawing the pellet twice. The
suspension was then transferred to a filter paper
disk (p 5mm) avoiding any contact with metal that
would interfere with the platinum determination.
The filter paper disks were air-dried before
measurement.
The X-rays emitted by the irradiated sample were
determined and analysed by a semi-conductor
spectrometer. The area of the analysed region of
the sample was given by the diameter of the proton
beam (3mm2). Detection limits are dependent on
the energy of the particles, the kind and purity of
substrates. In the case of platinum the detection
limit was -3.5ng/sample with a tolerance of about
8% at 20ng/sample and 17% at lOng/sample. For
calibration, 20,l samples of cisplatin, diluted in
Hank's solution to the appropriate concentration,
were used.
0
0)
!o
. 0A
2)
0.
c
0
so
n
C.) .0_
a
Drug concentration (Ag ml-')
Figure 1 The effect of various concentrations of
cisplatin on the surviving fraction of HeLa cells (a)
and Chinese hamster cells (b) at constant exposure
times: lh ( x-), 2h (-O-), 3h (-0-) and 4h
(-El-). Each point represents the mean (±s.d.) of at
least 10 dishes analysed on at least 3 different
occasions; single points give the mean of one
experiment.
Results
Cell survival as afunction ofcisplatin concentration
in the exposure medium
Figure 1 shows various curves of HeLa (a) and
Chinese hamster cells (b) with increasing drug
concentration and at given exposure times. A direct
comparison of drug sensitivity in all three cell lines
is shown in Figure 2 for 2h exposure time. In HeLa
and HaK cells survival is an exponential function
of cisplatin concentration in the medium for the
drug concentration range tested. For Chinese
hamster cells the survival curves have a shoulder at
low drug concentration followed by an exponential
decrease as a function of increasing drug concen-
tration in the medium. The CO, i.e. the
concentration in the medium necessary to reduce
the surviving fraction in the exponential part to
0.37 at a given exposure time of 2h is 0.6 gml-1
for HeLa cells, 1 Mgml-I for Chinese hamster cells
and 4.3Mgml- for HaK cells.
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Figure 2 Cell survival as a function of cisplatin
concentration of HeLa (- x-), Chinese hamster
(-O-) and HaK cells (-A-) at an exposure time
of 2 h.
Cell survival as afunction ofcisplatin exposure time
Figure 3 shows the survival curves of HeLa (a) and
Chinese hamster cells (b) with increasing exposure
times up to 4h at given drug concentrations. A
direct comparison of drug sensitivity in all three cell
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Figure 3 The effect of various exposure times on the
surviving fraction of HeLa cells (a) and Chinese
hamster cells (b) at constant cisplatin concentration:
l ,gml-l (-x-), 2Hgml - ( O ), 4Hgml -
(-E-), 6 ugml- (-A-). Each point represents
the mean (±s.d.) of at least 10 dishes analysed on at
least 3 different occasions; single points give the mean
of one experiment.
lines is shown in Figure 4 at a concentration of
4jugml-1. For all three cell lines, cell survival
decreases exponentially as cisplatin exposure time
increases. The T0, i.e. the exposure time necessary
to reduce the surviving fraction to 0.37 at a drug
concentration of 4 ugml-1, is 0.3h for HeLa cells,
0.7h for Chinese hamster cells and 2.7h for HaK
cells.
Cellular Pt - content as afunction ofdrug
concentration and exposure time
The cellular Pt-content of HeLa cells was measured
as a function of cisplatin concentration (exposure
time 6h) as well as a function of increasing
exposure time at constant drug concentration
(10Mgml-). There is a linear increase in cellular
Figure 4 Cell survival as a function of cisplatin
exposure time of HeLa (- x ), Chinese hamster
(-O-) and HaK cells (-A-) at a drug concen-
tration of4pgml-'.
Pt-content with increasing concentration of the
drug in the medium as well as with increasing
exposure time (Figure 5).
Measurement ofthe cellular platinum content ofthe
three cell lines
To study the cause of the difference in drug
sensitivity of the three cell lines we measured the
cellular platinum content per 106 cells in HeLa,
Chinese hamster and HaK cells under identical
exposure conditions. Figure 6 shows the results of
three different experiments. Cellular drug content
increases in proportion to extracellular drug
exposure dose in all three cell lines, but HeLa cells
contain 4.4 times more platinum than HaK cells at
any exposure time or concentration.
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Figure 5 Cellular platinum content of HeLa cells (ng
Pt 10-6 cells) as a function of increasing cisplatin
concentration in the medium (-O-, t=6h) or
increasing drug exposure time (- x -, c= lugml-1),
determined with proton induced X-ray emission.
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Figure 6 Dependence of cellular platinum content (ng
Pt 10-6 cells) on drug exposure dose (pg ml - .h) of
HeLa ( x ), Chinese hamster (-O ) and HaK
cells ( A-); see text for further details.
Discussion
The cytotoxic effect of cisplatin was measured in
three different cell lines for various drug concen-
trations and exposure times. For HeLa and HaK
cells survival is an exponential function of drug
exposure dose, which is the product of drug
concentration in the medium and exposure time
(D =c x t). Using all experimental results, a single
dose effect curve was computed for both HeLa and
HaK cells. The sensitivity of these cells to cisplatin
is characterized by the slope of the dose effect curve
which is 0.78 (pgmlP-1 .h) for HeLa and 0.11
(pgml- 1 . h) for HaK cells respectively. Thus, HeLa
cells are more sensitive to the cytotoxic action of
cisplatin under identical exposure conditions than
HaK cells by a factor of 7.
This simple form of dose effect curve was not
found for Chinese hamster cells: with increasing
drug concentration in the medium there was a
shoulder in the survival curve which may reflect the
capacity of cells to absorb damage without
expressing the lethal effect. The survival curve is
characterized by a shoulder followed by an
exponential part. Different cell sensitivities may be
compared at a low survival level: for Chinese
hamster cells more than twice the exposure time is
necessary at constant drug concentration to reduce
survival to 1% compared to HeLa cells.
The differences in cell sensitivity to cisplatin have
been shown to be correlated with differences in
DNA cross-linking by Laurent et al. (1981) and
Zwelling et al. (1981), which may be caused either
by differences in cisplatin transport into the cell or
by differences in the specific intracellular
metabolism of the drug. In order to study the first
possible mechanism, we measured the platinum
content of the three cell lines to compare exposure
dose and absorbed dose as a function of cisplatin
cytotoxicity. Under identical exposure conditions
HeLa cells contain 4.4 times more platinum than
HaK cells (Figure 6). The data suggest that
differences in cisplatin sensitivity of Hela and HaK
cells are mainly due to differences in drug uptake.
Replotting cell survival versus cellular platinum
content shows that cellular drug content necessary
to reduce survival to 1% does not vary significantly
for all three cell lines (Figure 7).
These results show that cellular drug content, i.e.
absorbed drug dose, is the important parameter to
define the effective drug dose in cisplatin cyto-
toxicity of different cell lines.
These results may be compared to those reported
by Fraval and Roberts (1979). The relative
sensitivity of HeLa and Chinese hamster cells to
cisplatin was proportional to relative platin binding
to DNA. They concluded that the extent of DNA
bound to the DNA is the major determinant of cell
survival. This inherent sensitivity differed between
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Figure 7 Dependence of the surviving fraction of
different cell lines on cellular drug content (ng Pt 10-6
cells); HeLa (- x ), Chinese hamster (-O-) and
HaK (-A-) cells; results of Figures 1-3 and
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cell lines and also through the cell cycle, which may
reflect differences in some DNA repair pathway.
According to our results, differences in cell
sensitivity to cisplatin may be due mainly to differ-
ences in platinum uptake through the membrane.
Consequently, the cell membrane as the main
barrier for cisplatin uptake appears to determine
the relative cisplatin sensitivity of cells in vitro. It is
of considerable interest whether the development of
drug resistance in cancer therapy is also due to
differences in drug uptake through alterations in
cell membrane structure. Changes in composition of
the cell membrane have been made responsible for
actinomycin D resistance (Peterson & Biedler, 1978)
but so far not for cisplatin activity (Seeber et al.,
1982).
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